Julian Harrison, an analyst from BTIG, reiterated the Buy rating on Cartesian Therapeutics (RNAC – Research Report). The associated price ...

Mitchell Kapoor, an analyst from H.C. Wainwright, reiterated the Buy rating on Cartesian Therapeutics (RNAC – Research Report). The associated ...

After hours: January 24 at 4:01:25 PM EST Loading Chart for RNAC ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

PRAX Praxis Precision Medicines, Inc.

We’ve highlighted our recent progress and outlined Cartesian’s 2025 strategic priorities across our pipeline of mRNA cell therapy candidates for the treatment of #autoimmune diseases.

Aaaaa Aaaaaa Aaa 197.58 +31.08% ...

Featured here, the Income Statement (earnings report) for Cartesian Therapeutics Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses ...